News
priMe AVAREF Meeting
The pivotal phase III infant vaccine trial was accepted by the African Vaccine Regulatory Forum (AVAREF) for a joint review process. The meeting has taken place from 22-24th of January 2020 in Nairobi, Kenya.
PhD award for Alexandra Hierweger
The VPM employee Alexandra Hierweger received the Uwe Koch-Gromus-PhD-Promotionspreis 2019 for her PhD thesis with the title 'Influence of influenza A virus infections on the maternal immune system during pregnancy'. The ceremony took place on 6th of December 2019 at the University Medical Center Hamburg-Eppendorf.
TB Vaccine Conference 2020
VPM will be participant and speaker at the TB vaccine conference in Les Diablerets, Switzerland, taking place from 27 – 29 January 2020.
PriMe Investigator Meeting
The priMe Investigator meeting has taken place from 27-28th of November 2019 in Dar es Salaam, Tanzania.
TRAIN lecture
VPM will give a lecture for the TRAIN academy on 7th November 2019 at TWINCORE with the title „ Methods for successful project management - achieving project goals faster and more securer."
World Health Summit 2019
VPM will take part in the World Health Summit from 27-29 October in Berlin.
Press release on the 12th International VPM Days 2019
On 12 and 13 September, the 12th International VPM Days took place at TWINCORE in Hannover. More than 20 international speakers and almost 100 visitors accepted the invitation of Vakzine Projekt Management GmbH (VPM). Read more!
BIO Europe 2019
VPM will take part in the BIO Europe from 11-13 November in Hamburg. It is Europe's largest partnering conference for global biotechnology industry and international forum for business development between pharmaceutical, financial and biotechnology companies.
TRAIN Kick-Off
VPM as partner of the TRAIN academy wants to invite people to come to the TRAIN kick-off meeting at TWINCORE on 17 October 2019.
VPM is part of a consulting Team for the European Commission within Horizon 2020 on Tuberculosis Vaccines
VPM will take part in the TB Meeting "Maintaining European scientific excellence and global leadership in TB Vaccine R&D" on 8 October 2019 in Brussels.